Multiparameter prediction model of immune checkpoint inhibitors combined with chemotherapy for non-small cell lung cancer based on support vector machine learning

The reliable predictive markers to identify which patients with advanced non-small cell lung cancer tumors (NSCLC) will achieve durable clinical benefit (DCB) for chemo-immunotherapy are needed. In this retrospective study, we collected radiomics and clinical signatures from 94 patients with advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zihan, Guo, Wenjie, Liu, Dingqi, Micha, Jose Ramon Nsue, Song, Yue, Han, Shuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024716/
https://www.ncbi.nlm.nih.gov/pubmed/36934139
http://dx.doi.org/10.1038/s41598-023-31189-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024716/
https://www.ncbi.nlm.nih.gov/pubmed/36934139
http://dx.doi.org/10.1038/s41598-023-31189-4

Ejemplares similares